TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Evogene ( (EVGN) ).
On November 20, 2025, Evogene Ltd. announced its financial results for the third quarter ending September 30, 2025, highlighting a strategic transition towards computational chemistry with a focus on small molecule design. The company reported a significant reduction in operating expenses due to organizational realignment and cost-reduction measures, resulting in a decrease in operating loss compared to the previous year. The sale of Lavie Bio’s assets and MicroBoost AI contributed to a strengthened cash position. Despite a decrease in overall revenue, Evogene is poised for growth with its AI-driven approach, aiming to redefine innovation in pharma and agriculture.
The most recent analyst rating on (EVGN) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Evogene stock, see the EVGN Stock Forecast page.
Spark’s Take on EVGN Stock
According to Spark, TipRanks’ AI Analyst, EVGN is a Neutral.
Evogene’s overall stock score is primarily impacted by its weak financial performance, characterized by declining revenues and high leverage. While the earnings call provided some positive developments, such as revenue growth and strategic initiatives, the ongoing financial challenges and bearish technical indicators weigh heavily on the stock’s outlook.
To see Spark’s full report on EVGN stock, click here.
More about Evogene
Evogene Ltd. is a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. The company focuses on leveraging its ChemPass AI platform to drive innovation and create value in these sectors.
Average Trading Volume: 79,617
Technical Sentiment Signal: Strong Sell
Current Market Cap: $10.2M
See more data about EVGN stock on TipRanks’ Stock Analysis page.